Industry

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CEO Kathryn Walker awarded Microdose’s “Professional Service Practitioner of the Year”, following last year’s win of “Entrepreneur of the Year” in 2021 at Wonderland: Miami, the largest psychedelic medicine business event. “I am honored to be included … [Read more…]

SEATTLE–(BUSINESS WIRE)–HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today it has been selected to join Blue Knight, a collaboration between Johnson & Johnson Innovation – JLABS (‘JLABS’) and the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response (ASPR), a part of the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Enteral Feeding Formulas Market Size, Share & Industry Trends Analysis Report By End User, By Application (Oncology, Neurological Disorders, Gastrointestinal Diseases, Diabetes), By Stage, By Product, By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Enteral Feeding Formulas Market size is expected to reach … [Read more…]

Fall Detect by KamiCare enables seniors to safely stay at home longer with greater peace of mind for caregivers SAN JOSE, Calif.–(BUSINESS WIRE)–On the heels of its successful General Availability launch of KamiCare, an artificial intelligence (AI) fall management solution for senior living communities, Kami Vision has announced Fall Detect by KamiCare, the world’s first … [Read more…]

BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a license agreement with LEXEO Therapeutics, Inc. (LEXEO), which will enable LEXEO to use Cerveau’s [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are a hallmark … [Read more…]

TAIPEI, Taiwan–(BUSINESS WIRE)–REGiMMUNE Limited, a clinical-stage biopharmaceutical company focused on creating innovative immunotherapies for immune disorders and cancer, today announced that the Phase 2b clinical data from 49 patients receiving RGI-2001 for the prevention of acute graft-versus-host disease (aGVHD) will be presented at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans, … [Read more…]

OTOF-GT targets the restoration of hearing in people living with otoferlin deficiency Sensorion is on track to file a CTA for OTOF-GT in H1 2023 MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, announces … [Read more…]

Positive result from interim analysis and reduction of the size of the Phase II trial evaluating TG4001 + avelumab vs avelumab in HPV-positive anogenital cancers Positive clinical data on TG4050 were presented during a R&D Day in Sept. 2022 €36.3 million in cash and cash equivalents as of September 30, 2022 Financial visibility until the … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Monday, November 14, 2022, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2022. Speakers during the … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Apros Therapeutics, Inc., a clinical stage biotechnology company focused on tissue-targeted Toll-Like Receptor 7 (TLR7) agonists for the treatment of advanced cancers and infectious diseases, today announced that they will present interim pharmacokinetic and pharmacodynamic Phase 1 clinical data for APR003 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting to … [Read more…]